Opthea to Present at Citi Global Healthcare Conference
Ticker: OPTEY · Form: 6-K · Filed: Nov 25, 2024 · CIK: 1815620
Sentiment: neutral
Topics: conference-participation, biotechnology, investor-relations
TL;DR
Opthea is presenting at the Citi Healthcare Conference on Nov 25th - watch for updates.
AI Summary
Opthea Limited announced on November 25, 2024, that it will participate in the Citi 2024 Global Healthcare Conference. The company will present its latest developments and strategic outlook at the conference, which is a significant event for the biotechnology and pharmaceutical sectors.
Why It Matters
Participation in major industry conferences like the Citi Global Healthcare Conference provides Opthea with a platform to showcase its progress and pipeline to investors and industry peers, potentially influencing its stock valuation and future partnerships.
Risk Assessment
Risk Level: low — This filing is an announcement of participation in a conference, not a material financial event or change in business operations.
Key Players & Entities
- Opthea Limited (company) — Registrant
- Citi 2024 Global Healthcare Conference (company) — Event
- November 25, 2024 (date) — Announcement Date
FAQ
What is the purpose of this 6-K filing?
This 6-K filing serves as a report of foreign issuer and includes a press release announcing Opthea Limited's participation in the Citi 2024 Global Healthcare Conference.
When was this report filed?
This report was filed on November 25, 2024.
Which conference will Opthea Limited be participating in?
Opthea Limited will be participating in the Citi 2024 Global Healthcare Conference.
What is Opthea Limited's principal executive office address?
Opthea Limited's principal executive office is located at Level 4, 650 Chapel Street, South Yarra, Victoria, 3141, Australia.
Does Opthea Limited file annual reports under Form 20-F or 40-F?
Opthea Limited files its annual reports under cover of Form 20-F.
Filing Stats: 151 words · 1 min read · ~1 pages · Grade level 13.5 · Accepted 2024-11-25 06:02:36
Filing Documents
- opt_-_opthea_citi_confer.htm (6-K) — 24KB
- opt-ex99_1.htm (EX-99.1) — 19KB
- img260626642_0.jpg (GRAPHIC) — 61KB
- img260626642_1.jpg (GRAPHIC) — 61KB
- 0000950170-24-130414.txt ( ) — 212KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Frederic Guerard Name: Frederic Guerard Title: Chief Executive Officer Date: 11/25/2024